Table 3:
Association of demographic and clinical characteristics with prescription for antibiotics within 7 days of the annual evaluation.
Unadjusted OR (95% CI) |
p-value | Adjusted OR (95% CI) |
p-value | |
---|---|---|---|---|
Age | 1.00 (0.99–1.0) | 0.71 | 1.00 (0.99–1.01) | 0.40 |
Race | ||||
White | Reference | Reference | ||
Black | 0.71 (0.61–0.84) | 0.01 | 0.70 (0.59–0.83) | <0.01 |
Other | 0.81 (0.64–1.01) | 0.69 | 0.84 (0.66–1.07) | 0.16 |
Ethnicity | ||||
Non-Hispanic | Reference | Reference | ||
Hispanic | 1.12 (0.89–1.40) | 0.05 | 1.06 (0.80–1.40) | 0.69 |
Unknown | 0.72 (0.51–1.02) | 0.03 | 0.51 (0.32–0.82) | 0.01 |
Gender | ||||
Male | Reference | Reference | ||
Female | 1.41(1.05–1.88) | 0.02 | 1.22 (0.84–1.76) | 0.29 |
Neurologic Level of Injury | ||||
Tetraplegia AIS A-C | Reference | Reference | ||
Paraplegia AIS A-C | 1.08 (0.90–1.30) | <0.01 | 1.16 (0.92–1.47) | 0.20 |
AIS D | 0.67 (0.56–0.81) | <0.01 | 1.01 (0.80–1.28) | 0.92 |
Not Classified | 0.83 (0.67–1.03) | 0.38 | 1.11 (0.83–1.47) | 0.48 |
Etiology of Injury | ||||
Motor Vehicle Collision | Reference | Reference | ||
Fall | 0.82 (0.66–1.00) | 0.16 | 0.97 (0.77–1.25) | 0.83 |
Other | 0.87 (0.75–1.01) | 0.54 | 1.03 (0.86–1.20) | 0.80 |
Comorbidity Index | 1.05 (1.01–1.09) | 0.02 | 1.06 (1.01–1.11) | 0.03 |
Bladder Management | ||||
Catheter | Reference | Reference | ||
No Catheter | 0.47 (0.42–0.54) | <0.01 | 0.68 (0.57–0.82) | <0.01 |
Organism Identified on Culture in Top 3 | ||||
Yes | Reference | Reference | ||
No | 0.42 (0.37–0.47) | <0.01 | 0.48 (0.41–0.57) | <0.01 |
Urine Culture During Annual Evaluation | ||||
Yes | Reference | Reference | ||
No | 0.51 (0.45–0.59) | <0.01 | 0.62 (0.51–0.75) | <0.01 |